Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis-Reference-Cited by-同舟云学术

Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis

Published:2022-04-27 Issue:8 Volume:49 Page:769-774
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:The Journal of Dermatology

Author:

Bomze David¹^ORCID,Sprecher Eli¹,Geller Shamir¹^ORCID

Affiliation:

1. Division of Dermatology Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine Tel Aviv Israel

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.16398

Reference15 articles.

1. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

2. Flawed ivermectin preprint highlights challenges of COVID drug studies

3. WHO joins Europe Merck in recommending against ivermectin for COVID‐19. Reuters [Internet]. 2021 Mar 31. Available from:https://www.reuters.com/article/us‐health‐coronavirus‐ivermectin‐idUSKBN2BN2HH

4. Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS)

5. Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System;Journal of Cutaneous Medicine and Surgery;2024-01

2. Id reaction following the treatment of a cutaneous larva migrans;JAAD Case Reports;2023-08

3. Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database;Frontiers in Pharmacology;2023-04-04

4. Quoi de neuf en dermatologie clinique ?;Annales de Dermatologie et de Vénéréologie - FMC;2022-12

5. Ivermectin/valproic acid;Reactions Weekly;2022-06